Skip to main content
Year archive

ACRUX LIMITED — 2015 filings

All 38 regulatory filings released by ACRUX LIMITED (ACR) in 2015, sourced directly from the official regulator.

38 Filings
2015 Period
2015 filings (38)
Filing Released Lang
2015 AGM Presentation and Script 51 pages 3.1MB
Regulatory Filings
2015-11-16 English
2015 AGM Results of Meeting 1 page 62.2KB
Declaration of Voting Results & Voting Rights Announcements
2015-11-16 English
Axiron Net Sales, quarter to September 2015 1 page
Earnings Release
2015-10-22 English
Notice of 2015 Annual General Meeting and Proxy Form 7 pages 545.8KB
AGM Information
2015-10-14 English
Acrux 2015 Annual Report 72 pages 1.9MB
Regulatory Filings
2015-10-14 English
Notice of 2015 Annual Genral Meeting, Proxy Form and ESOP 23 pages 679.6KB
AGM Information
2015-10-14 English
Acrux presents at AusBiotech Invest 11 pages 1.1MB
Investor Presentation
2015-10-07 English
European approvals and milestone payments for Lenzetto 2 pages 123.5KB
Capital/Financing Update
2015-09-06 English
Investor Presentation 20 August 2015 17 pages 1.5MB
Investor Presentation
2015-08-19 English
Ceasing to be a substantial holder 3 pages 72.4KB
Regulatory Filings
2015-08-13 English
Acrux announces 2015 Financial Result and Dividend 82 pages 2.1MB
Regulatory Filings
2015-08-12 English
Dividend/Distribution - ACR 4 pages 33.6KB
Notice of Dividend Amount
2015-08-12 English
Change in substantial holding 5 pages 240.0KB
Regulatory Filings
2015-08-11 English
Full Year Results Investor Conference Call 2 pages 369.7KB
Call Transcript
2015-08-11 English
Change in substantial holding 5 pages 225.2KB
Regulatory Filings
2015-08-06 English
Change in substantial holding 13 pages 862.8KB
Regulatory Filings
2015-08-04 English
Issue of Options 15 pages 4.6MB
Regulatory Filings
2015-08-03 English
Ceasing to be a substantial holder 10 pages 825.1KB
Regulatory Filings
2015-07-28 English
Axiron Net Sales, quarter to June 2015 2 pages 411.6KB
Capital/Financing Update
2015-07-23 English
Appointment of leadership positions 1 page 359.8KB
Board/Management Information
2015-07-12 English
Lilly and Acrux file lawsuit against Lupin 1 page 3
Legal Proceedings Report
2015-07-06 English
Axiron Net Sales, quarter to March 2015 1 page 103.
Earnings Release
2015-04-23 English
Change in substantial holding 4 pages 130.8KB
Major Shareholding Notification
2015-03-09 English
FDA Testosterone update 7 pages 181.2KB
Regulatory Filings
2015-03-03 English
Call on the FDA Drug Safety Communication 2 pages 238.3KB
Regulatory Filings
2015-03-03 English
Appendix 4D - 31 December 2014 5 pages 168.9KB
Interim / Quarterly Report
2015-02-25 English
Half-Year Financial Report 19 pages 5.9MB
Regulatory Filings
2015-02-25 English
Half-Year Results Presentation - 31 December 2014 11 pages 1.1MB
Regulatory Filings
2015-02-25 English
Director Resignation 2 pages 248.6KB
Board/Management Information
2015-02-25 English
Half-year earnings call for the period ended 31 Dec 2014 1
Regulatory Filings
2015-02-22 English
Ceasing to be a substantial holder 3 pages 138.9KB
Regulatory Filings
2015-02-12 English
Change in substantial holding 5 pages 163.2KB
Regulatory Filings
2015-02-05 English
2015 EGM Chairman's Address and Presentation 6 pages 275.7KB
Call Transcript
2015-02-02 English
2015 EGM Results of Meeting 1 page 298.3KB
Regulatory Filings
2015-02-02 English
Axiron Net Sales, quarter to 31 December 2014 1 pag
Capital/Financing Update
2015-02-01 English
Change in substantial holding 5 pages 379.6KB
Regulatory Filings
2015-01-29 English
Change in substantial holding 5 pages 369.1KB
Regulatory Filings
2015-01-20 English
Change in substantial holding 6 pages 433.0KB
Regulatory Filings
2015-01-06 English